疫苗接种对苏格兰肾衰竭患者SARS-CoV-2感染发病率和结局的影响
该观察性数据链接队列研究纳入苏格兰接受肾脏替代治疗的肾衰竭人群,截至2021年9月19日93%(n=5281)已接种两剂获批SARS-CoV-2疫苗;全程接种对感染和住院的疫苗有效性分别为33%(95%CI 0-52)和38%(95%CI 0-57),SARS-CoV-2阳性PCR检测后28天内9.2%的全程接种者死亡(透析患者7%、肾移植受者10%)。
要点
- 两剂疫苗对KRT人群感染的疫苗有效性为33%(95%CI 0-52)。
- 两剂疫苗对KRT人群住院的疫苗有效性为38%(95%CI 0-57)。
- SARS-CoV-2阳性后28天内全程接种者死亡比例9.2%(透析7%、移植10%)。
核心结论
- 两剂初级疫苗程序对接受肾脏替代治疗患者的COVID-19感染及其并发症效果有限。
- 亟需辅助策略以降低该人群COVID-19感染及其并发症风险。
研究设计与样本
- 研究设计为观察性数据链接队列研究。
- 链接多个医疗数据集,纳入自疫情开始起20个月内苏格兰所有接受肾脏替代治疗的患者,获取全部SARS-CoV-2检测、疫苗接种、住院和死亡数据。
- 采用描述性统计、生存分析和疫苗有效性计算。
主要发现
- 截至2021年9月19日,苏格兰已确诊KRT人群中93%(n=5281)已接种两剂获批SARS-CoV-2疫苗。
- 研究期间共814例SARS-CoV-2感染,占KRT人群的15.1%。
- 疫苗对感染的有效性为33%(95%CI 0-52),对住院的有效性为38%(95%CI 0-57)。
- SARS-CoV-2阳性PCR检测后28天内,9.2%的全程接种者死亡(透析患者7%、肾移植受者10%)。
- 同期接种疫苗的苏格兰普通人群中因COVID-19住院或死亡的比例<0.1%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with kidney failure requiring KRT are at high risk of complications and death following SARS-CoV-2 infection, with variable antibody responses to vaccination reported. We investigated the effects of COVID-19 vaccination on the incidence of infection, hospitalization, and death from COVID-19 infection. METHODS: The study design was an observational data linkage cohort study. Multiple health care datasets were linked to ascertain all SARS-CoV-2 testing, vaccination, hospitalization, and mortality data for all patients treated with KRT in Scotland from the start of the pandemic over a period of 20 months. Descriptive statistics, survival analyses, and vaccine effectiveness were calculated. RESULTS: As of September 19, 2021, 93% (n=5281) of the established KRT population in Scotland had received two doses of an approved SARS-CoV-2 vaccine. Over the study period, there were 814 cases of SARS-CoV-2 infection (15.1% of the KRT population). Vaccine effectiveness rates against infection and hospitalization were 33% (95% CI, 0 to 52) and 38% (95% CI, 0 to 57), respectively. Within 28 days of a SARS-CoV-2-positive PCR test, 9.2% of fully vaccinated individuals died (7% patients on dialysis and 10% kidney transplant recipients). This compares to <0.1% of the vaccinated general Scottish population admitted to the hospital or dying due to COVID-19 during that period. CONCLUSIONS: These data demonstrate that a primary vaccine course of two doses has limited effect on COVID-19 infection and its complications in patients with KRT. Adjunctive strategies to reduce risk of both COVID-19 infection and its complications in this population are urgently required.
引用
- Bell S, Campbell J, Lambourg E, et al. The Impact of Vaccination on Incidence and Outcomes of SARS-CoV-2 Infection in Patients with Kidney Failure in Scotland. J Am Soc Nephrol. 2022. PMID: 35110363. doi:10.1681/ASN.2022010046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。